Biomarker staging of liver fibrosis in hepatitis C was cost effective, but so was initiating treatment without testing.

In 2023, the United States represented the largest portion of the Liver Fibrosis market, comprising around 79% of the total ...

The growing emphasis on advanced liver fibrosis treatments highlights a paradigm shift in addressing chronic liver diseases, ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously called non-alcoholic fatty liver disease, is a ...

The therapy showed a ‘favourable’ safety profile both as a single agent and in combination with standard-of-care treatment.

Child's Pose is a gentle resting posture that's helpful for reducing stress and anxiety. Kneel on the floor, sit back on your ...

The liver, serving as the body's natural filtration system, faces significant challenges from alcohol consumption. As this ...

Cirrhosis is the severe scarring or fibrosis of the liver. It happens in the late stage ... with cirrhosis is usually irreversible, but treatment can help manage it. Causes of cirrhosis include ...

Patients with indeterminate chronic hepatitis B (CHB) phase are at risk of progressing to advanced liver disease and hepatocellular carcinoma (HCC), according to study results published in the Journal ...

“We also observed an initial decrease in ALT/AST in liver fibrosis patients treated with lixudebart.” Developed for the treatment of fibrosis in the liver, lungs and kidneys, lixudebart ...